| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $11.95M | - | |
| CFO | 123.3K | $6.86M | - | |
| VP | 84.1K | $4.68M | - | |
| VP | 61.0K | $3.40M | - | |
| Dir | 49.4K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 8, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 10,000 | $96.09 | $960,850.00 | -4.0% | |
| May 5, 2017 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sale+OE | 4,486 | $99.00 | $444,114.00 | -8.0% | |
| May 5, 2017 | George Eric Davis65 | EVP, General Counsel | Sale+OE | 2,500 | $100.34 | $250,852.50 | -2.8% | |
| May 2, 2017 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 302 | $96.74 | $29,215.48 | -0.6% | |
| Apr 27, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 5,000 | $95.72 | $478,600.00 | -2.1% | |
| Apr 25, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 5,000 | $94.00 | $470,000.00 | -2.1% | |
| Mar 29, 2017 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 3,890 | $89.15 | $346,793.50 | -7.0% | |
| Mar 16, 2017 | Daniel K Spiegelman59 | EVP, Chief Financial Officer | Sell | 1,989 | $91.96 | $182,908.44 | -12.1% | |
| Mar 16, 2017 | George Eric Davis65 | EVP, General Counsel | Sell | 2,238 | $91.96 | $205,806.48 | -2.9% | |
| Mar 16, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 10,000 | $91.69 | $916,900.00 | -5.0% |